Rankings
▼
Calendar
MESO Q3 2017 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena
MESO
Mesoblast Limited
$2B
Q3 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$901,000
-78.2% YoY
Gross Profit
-$3M
-325.1% margin
Operating Income
-$22M
-2441.1% margin
Net Income
-$10M
-1085.9% margin
EPS (Diluted)
$-0.18
QoQ Revenue Growth
+63.8%
Cash Flow
Operating Cash Flow
-$26M
Free Cash Flow
-$26M
Stock-Based Comp.
$746,000
Balance Sheet
Total Assets
$679M
Total Liabilities
$139M
Stockholders' Equity
$540M
Cash & Equivalents
$50M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$901,000
$4M
-78.2%
Gross Profit
-$3M
-$4M
+18.2%
Operating Income
-$22M
-$20M
-7.5%
Net Income
-$10M
-$17M
+42.2%
← FY 2017
All Quarters
Q4 2017 →